The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
PML Contributes to a Cellular Mechanism of Repression of Herpes Simplex Virus Type 1 Infection That Is Inactivated by ICP0
Abstract
Promyelocytic leukemia (PML) nuclear bodies (also known as ND10) are nuclear substructures that contain several proteins, including PML itself, Sp100, and hDaxx. PML has been implicated in many cellular processes, and ND10 are frequently associated with the replicating genomes of DNA viruses. During herpes simplex virus type 1 (HSV-1) infection, the viral regulatory protein ICP0 localizes to ND10 and induces the degradation of PML, thereby disrupting ND10 and dispersing their constituent proteins. ICP0-null mutant viruses are defective in PML degradation and ND10 disruption, and concomitantly they initiate productive infection very inefficiently. Although these data are consistent with a repressive role for PML and/or ND10 during HSV-1 infection, evidence in support of this hypothesis has been inconclusive. By use of short interfering RNA technology, we demonstrate that depletion of PML increases both gene expression and plaque formation by an ICP0-negative HSV-1 mutant, while having no effect on wild-type HSV-1. We conclude that PML contributes to a cellular antiviral repression mechanism that is countered by the activity of ICP0.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T. M., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,798
Ishov, A. M., Sotnikov, A. G., Negorev, D., Vladimirova, O. V., Neff, N., Kamitani, T., Yeh, E. T. H., Strauss, J. F., & Maul, G. G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.2.221 · Cited by 832
The transcriptional role of PML and the nuclear body
Zhong, S., Salomoni, P., & Pandolfi, P. P. (2000) · Nature Cell Biology · doi:10.1038/35010583 · Cited by 577
Role of SUMO-1–modified PML in nuclear body formation
Zhong, S., Müller, S., Ronchetti, S., Freemont, P. S., Dejean, A., & Pandolfi, P. P. (2000) · Blood · doi:10.1182/blood.v95.9.2748.009k31a_2748_2752 · Cited by 561
The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion.
Koken, M. H., Puvion-Dutilleul, F., Guillemin, M. C., Viron, A., Linares-Cruz, G., Stuurman, N., de Jong, L., Szostecki, C., Calvo, F., & Chomienne, C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06356.x · Cited by 499
PML protein isoforms and the RBCC/TRIM motif
Jensen, K., Shiels, C., & Freemont, P. S. (2001) · Oncogene · doi:10.1038/sj.onc.1204765 · Cited by 467
Stow, N. D., & Stow, E. C. (1986) · Journal of General Virology · doi:10.1099/0022-1317-67-12-2571 · Cited by 415
Everett, R. D., Freemont, P., Saitoh, H., Dasso, M., Orr, A., Kathoria, M., & Parkinson, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6581-6591.1998 · Cited by 402
Self-citationSamaniego, L. A., Neiderhiser, L., & DeLuca, N. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.3307-3320.1998 · Cited by 372
Chelbi-Alix, M. K., & de Thé, H. (1999) · Oncogene · doi:10.1038/sj.onc.1202366 · Cited by 332
Sternsdorf, T., Jensen, K., & Will, H. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.7.1621 · Cited by 331
Pondering the Promyelocytic Leukemia Protein (PML) Puzzle: Possible Functions for PML Nuclear Bodies
Borden, K. L. B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5259-5269.2002 · Cited by 313
Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure.
Doucas, V, Ishov, A. M., Romo, A., Juguilon, H., Weitzman, M. D., Evans, R. M., & Maul, G. G. (1996) · Genes & Development · doi:10.1101/gad.10.2.196 · Cited by 311
Müller, S., & Dejean, A. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.5137-5143.1999 · Cited by 304
ICP0, a regulator of herpes simplex virus during lytic and latent infection
Everett, R. D. (2000) · BioEssays · doi:10.1002/1521-1878(200008)22:8<761::aid-bies10>3.0.co;2-a · Cited by 299
Self-citationSaffert, R. T., & Kalejta, R. F. (2006) · Journal of Virology · doi:10.1128/jvi.80.8.3863-3871.2006 · Cited by 284
Role and fate of PML nuclear bodies in response to interferon and viral infections
Regad, T., & Chelbi-Alix, M. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204854 · Cited by 281
Nuclear Domain 10 as Preexisting Potential Replication Start Sites of Herpes Simplex Virus Type-1
MAUL, G. G., ISHOV, A. M., & EVERETT, R. D. (1996) · Virology · doi:10.1006/viro.1996.0094 · Cited by 262
Self-citationNegorev, D., & Maul, G. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204764 · Cited by 258
A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies
Stuurman, N., Graaf, A. D., Floore, A., Josso, A., Humbel, B., Jong, L. D., & Driel, R. V. (1992) · Journal of Cell Science · doi:10.1242/jcs.101.4.773 · Cited by 256
DNA viruses and viral proteins that interact with PML nuclear bodies
Everett, R. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204759 · Cited by 246
Self-citationA role for PML and the nuclear body in genomic stability
Zhong, S., Hu, P., Ye, T.-Z., Stan, R., Ellis, N. A., & Pandolfi, P. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203367 · Cited by 230
Role of ICP0 in the Strategy of Conquest of the Host Cell by Herpes Simplex Virus 1
Hagglund, R., & Roizman, B. (2004) · Journal of Virology · doi:10.1128/jvi.78.5.2169-2178.2004 · Cited by 219
Everett, R. D., & Murray, J. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.5078-5089.2005 · Cited by 211
Self-citationTavalai, N., Papior, P., Rechter, S., Leis, M., & Stamminger, T. (2006) · Journal of Virology · doi:10.1128/jvi.00743-06 · Cited by 210
Self-citationPromyelocytic Leukemia Protein Mediates Interferon-Based Anti-Herpes Simplex Virus 1 Effects
Chee, A. V., Lopez, P., Pandolfi, P. P., & Roizman, B. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.7101-7105.2003 · Cited by 194
Role of PML and the PML-nuclear body in the control of programmed cell death
Bernardi, R., & Pandolfi, P. P. (2003) · Oncogene · doi:10.1038/sj.onc.1207106 · Cited by 188
Yao, F., & Schaffer, P. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.10.6249-6258.1995 · Cited by 178
Parkinson, J., & Everett, R. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10006-10017.2000 · Cited by 171
Self-citationRepression of viral transcription during herpes simplex virus latency
Preston, C. M. (2000) · Microbiology · doi:10.1099/0022-1317-81-1-1 · Cited by 160
Canning, M., Boutell, C., Parkinson, J., & Everett, R. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402885200 · Cited by 147
Self-citationEverett, R. D., Boutell, C., & Orr, A. (2004) · Journal of Virology · doi:10.1128/jvi.78.4.1763-1774.2004 · Cited by 136
Self-citationAhn, J.-H., & Hayward, G. S. (2000) · Virology · doi:10.1006/viro.2000.0448 · Cited by 128
Sternsdorf, T., Guldner, H. H., Szostecki, C., Grötzinger, T., & Will, H. (1995) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1995.tb03652.x · Cited by 125
Pluta, A. F., Earnshaw, W. C., & Goldberg, I. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.14.2029 · Cited by 124
Preston, C. M., & Nicholl, M. J. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.7807-7813.1997 · Cited by 101
Lopez, P., Jacob, R. J., & Roizman, B. (2002) · Journal of Virology · doi:10.1128/jvi.76.18.9355-9367.2002 · Cited by 67
Hoppé, A., Beech, S. J., Dimmock, J., & Leppard, K. N. (2006) · Journal of Virology · doi:10.1128/jvi.80.6.3042-3049.2006 · Cited by 65
Guldner, H. H., Szostecki, C., Schröder, P., Matschl, U., Jensen, K., Lueders, C., Will, H., & Sternsdorf, T. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.5.733 · Cited by 59
The promyelocytic leukemia nuclear body: sites of activity?
Eskiw, C. H., & Bazett‐Jones, D. P. (2002) · Biochemistry and Cell Biology · doi:10.1139/o02-079 · Cited by 52
Everett, R. D., & Zafiropoulos, A. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11411-11415.2004 · Cited by 27
Self-citation
Cited by
TRIM family proteins and their emerging roles in innate immunity
Ozato, K., Shin, D.-M., Chang, T.-H., & Morse, H. C. (2008) · Nature Reviews Immunology · doi:10.1038/nri2413 · Cited by 1,120
Lallemand-Breitenbach, V., & de The, H. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000661 · Cited by 563
Chromatin control of herpes simplex virus lytic and latent infection
Knipe, D. M., & Cliffe, A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1794 · Cited by 444
PML and PML nuclear bodies: Implications in antiviral defence
Everett, R. D., & Chelbi-Alix, M. K. (2007) · Biochimie · doi:10.1016/j.biochi.2007.01.004 · Cited by 439
Self-citationPathogenesis and virulence of herpes simplex virus
Zhu, S., & Viejo-Borbolla, A. (2021) · Virulence · doi:10.1080/21505594.2021.1982373 · Cited by 376
Metadata
- Authors
- Everett, R. D., Rechter, S., Papior, P., Tavalai, N., Stamminger, T., & Orr, A.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2006-08-15
- Volume
- 80
- Issue
- 16
- Pages
- 7995-8005
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W1968697793
- Cited by
- 327
- References
- 41
- FWCI
- 17.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.